Anthropic, a leading AI lab, is now set to market its initial public offering (IPO) in November 2026, having postponed its planned debut from October. If the company reaches a $2 trillion valuation, which some investors anticipate, it could result in one of the largest IPOs in history.

Read More

Currently, there is significant demand from investors eager to gain exposure to Anthropic’s innovative AI models. One of the more unconventional methods to access this opportunity is through synthetic perpetual futures contracts, such as those available on the Hyperliquid platform. Similar contracts were offered for Space Exploration Technologies prior to its market introduction.

These perpetual futures contracts have been trading since August 19, launched by a third-party developer. They allow investors to leverage bets on the price movements of Anthropic shares without an expiration date. As of September 30, the prices of these contracts implied an average valuation of $2 trillion for the company, more than double its valuation of $965 billion from a May 2026 funding round.

However, perpetual contracts may not be the best option for most investors looking for ownership in Anthropic. These synthetic instruments do not provide real equity in the company and cannot be converted into shares post-IPO. Additionally, holding these contracts incurs costs associated with funding payments that are not applicable to actual stockholders.

Given these drawbacks, purchasing synthetic pre-IPO instruments is not advisable for those looking to benefit from Anthropic’s upcoming IPO. Investors should exercise caution and refrain from investing in Anthropic until its audited financials are made public.

An S-1 registration statement was filed confidentially, and while Reuters has obtained some details, including a recorded net loss of $42 billion in 2025, the full document will reveal the company's financial performance for 2026 for the first time. Without this crucial information, investors cannot accurately assess the potential value of the company at the anticipated IPO valuation.